Nivolumab in real-life clinical practice by M. A. Lyadova, O. A. Pardabekova, R. R. Shakirov, V. K. Lyadov, M. Yu. Fedyanin

Get full text

Results of combined nivolumab and ipilimumab therapy in patients with cancer by M. A. Lyadova, V. K. Lyadov, O. A. Pardabekova, I. A. Pokataev, M. E. Ivannikov, Ya. V. Koroleva, E. S. Chernysheva, K. V. Lyadov

Get full text

Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study by M.   Yu. Fedyanin, F.   V. Moiseenko, M.   A. Lyadova, V.  N.  Vorobyeva, V.  V.  Petkau, A.  V.  Fateeva, E.  S.  Kuzmina, O.  Yu.  Novikova, V.   A. Chubenko, N.  Kh.  Abduloeva, A.  A.  Kudryavtsev, E.   O. Ignatova, R.   R. Shakirov, O.  A.  Pardabekova, L.  V.  Kindyalova, S.  P.  Pelikh, O.   A. Gladkov, S.  A.  Tjulandin, A.  A.  Tryakin

Get full text